Literature DB >> 28858293

Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.

Yan-Qiong Zhang1, Qiu-Yan Guo1, Qiu-Yue Li1, Wei-Qiong Ren2, Shi-Huan Tang1, Song-Song Wang3, Ri-Xin Liang1, De-Feng Li1, Yi Zhang1, Hai-Yu Xu1, Hong-Jun Yang1.   

Abstract

Guanxinjing capsules (GXJCs) are used in traditional Chinese medicine as a common therapy for coronary heart disease (CHD) complicated with depression. In this study, we aimed to identify the main active constituents in GXJCs and to investigate the mechanisms of GXJC action on CHD complicated with depression. The chemical constituent profile of the GXJC was identified by UHPLC-LTQ-Orbitrap assay, and oral bioavailability was evaluated to screen the GXJC drug-like chemical constituents. A total of 16 GXJC drug-like chemical constituents were identified. Then, putative targets of the GXJC drug-like chemical constituents were predicted using MedChem Studio, with 870 genes found to be the putative targets of these molecules. After that, a GXJC putative target-known CHD/depression therapeutic target network was constructed, and four topological features, including degree, betweenness, closeness and K-coreness, were calculated. According to the topological feature values of the GXJC putative targets, 14 main active constituents were identified because their corresponding putative targets had topological importance in the GXJC putative target-known CHD/depression therapeutic target network, which were defined as the candidate targets of GXJC against CHD complicated with depression. Functionally, these candidate targets were significantly involved in several CHD/depression-related pathways, including repairing pathological vascular changes, reducing platelet aggregation and inflammation, and affecting patient depression. This study identified a list of main active constituents of GXJC acting on CHD complicated with depression using an integrative pharmacology-based approach that combined active chemical constituent identification, drug target prediction and network analysis. This method may offer an efficient way to understand the pharmacological mechanisms of traditional Chinese medicine prescriptions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28858293      PMCID: PMC6256267          DOI: 10.1038/aps.2017.117

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  45 in total

1.  PDZBase: a protein-protein interaction database for PDZ-domains.

Authors:  Thijs Beuming; Lucy Skrabanek; Masha Y Niv; Piali Mukherjee; Harel Weinstein
Journal:  Bioinformatics       Date:  2004-10-28       Impact factor: 6.937

Review 2.  Trends in the incidence and mortality of coronary heart disease in asian pacific region: the Singapore experience.

Authors:  Chin Meng Khoo; E Shyong Tai
Journal:  J Atheroscler Thromb       Date:  2014       Impact factor: 4.928

3.  Simultaneous quantification of 17 constituents from Yuanhu Zhitong tablet using rapid resolution liquid chromatography coupled with a triple quadrupole electrospray tandem mass spectrometry.

Authors:  Yingchun Zhang; Haiyu Xu; Xiaomeng Chen; Chang Chen; Haijun Wang; Fanyun Meng; Hongjun Yang; Luqi Huang
Journal:  J Pharm Biomed Anal       Date:  2011-06-16       Impact factor: 3.935

4.  Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Authors:  Shantel A Vital; Felix Becker; Paul M Holloway; Janice Russell; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

5.  Online predicted human interaction database.

Authors:  Kevin R Brown; Igor Jurisica
Journal:  Bioinformatics       Date:  2005-01-18       Impact factor: 6.937

Review 6.  Depression, mortality, and medical morbidity in patients with coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

7.  Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach.

Authors:  Xu Haiyu; Shi Yang; Zhang Yanqiong; Jia Qiang; Li Defeng; Zhang Yi; Liu Feng; Yang Hongjun
Journal:  Mol Biosyst       Date:  2016-01

8.  A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma.

Authors:  Yanqiong Zhang; Xiaodong Guo; Danhua Wang; Ruisheng Li; Xiaojuan Li; Ying Xu; Zhenli Liu; Zhiqian Song; Ya Lin; Zhiyan Li; Na Lin
Journal:  Sci Rep       Date:  2014-02-24       Impact factor: 4.379

9.  Reactome knowledgebase of human biological pathways and processes.

Authors:  Lisa Matthews; Gopal Gopinath; Marc Gillespie; Michael Caudy; David Croft; Bernard de Bono; Phani Garapati; Jill Hemish; Henning Hermjakob; Bijay Jassal; Alex Kanapin; Suzanna Lewis; Shahana Mahajan; Bruce May; Esther Schmidt; Imre Vastrik; Guanming Wu; Ewan Birney; Lincoln Stein; Peter D'Eustachio
Journal:  Nucleic Acids Res       Date:  2008-11-03       Impact factor: 16.971

10.  DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali
Journal:  Nucleic Acids Res       Date:  2007-11-29       Impact factor: 16.971

View more
  6 in total

1.  New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Yong-Yan Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06       Impact factor: 6.150

2.  Study on the Mechanism of Ginseng in the Treatment of Lung Adenocarcinoma Based on Network Pharmacology.

Authors:  Qiu-Yue Li; Cheng-Zhi Hou; Li-Ping Yang; Xue-Lei Chu; Yuan Wang; Ping Zhang; Yong Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-31       Impact factor: 2.629

3.  Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation.

Authors:  Zihao Wang; Ke-Gang Linghu; Yuanjia Hu; Huali Zuo; Hao Yi; Shi-Hang Xiong; Jinjian Lu; Ging Chan; Hua Yu; Run-Yue Huang
Journal:  Front Pharmacol       Date:  2019-09-23       Impact factor: 5.810

4.  Paeonol at Certain Doses Alleviates Aggressive and Anxiety-Like Behaviours in Two Premenstrual Dysphoric Disorder Rat Models.

Authors:  Hao Zhang; Xiwen Geng; Zifa Li; Yaqiong Li; Kaiyong Xu; Hongyun Wu; Jinlu Xie; Peng Sun; Sheng Wei; Mingqi Qiao
Journal:  Front Psychiatry       Date:  2020-04-15       Impact factor: 4.157

5.  Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer's Disease.

Authors:  Quan Li; Qi Wang; Huibo Guan; Yanyan Zhou; Li Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-29       Impact factor: 2.570

Review 6.  A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine.

Authors:  Haiyu Xu; Yanqiong Zhang; Ping Wang; Junhong Zhang; Hong Chen; Luoqi Zhang; Xia Du; Chunhui Zhao; Dan Wu; Feng Liu; Hongjun Yang; Changxiao Liu
Journal:  Acta Pharm Sin B       Date:  2021-03-20       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.